Clinical Trial Update: Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating how fulvestrant affects estrogen receptor binding site availability using molecular imaging in metastatic breast cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED